TALKING ABOUT PROSTATE CANCER AND PYLARIFY®. CLEARLY.

Not an actual patient.

Ongoing checkups and screenings are important steps you and your doctor can take to monitor prostate cancer. To help get a clearer image of the cancer and consider available treatment options, your doctor may discuss doing a PET/CT scan with PYLARIFY®.

QUESTIONS TO DISCUSS WITH YOUR DOCTOR

Here are a few questions to help you start or continue the conversation with your doctor:

Based on the initial diagnosis assessment, or if the prostate cancer has come back (recurred), or spread (metastasized), how can imaging options help determine the extent of the cancer?
Is a PET/CT scan with PYLARIFY® an option for me?
Can you talk to me about PET/CT scans and how safe they are?

Drink fluids before and after your scan. Staying properly hydrated and going to the bathroom are important pre- and post-scan

With PYLARIFY®, fasting might not be required. Although fasting before a PYLARIFY® PET/CT scan is not required, your doctor might ask you to

If your doctor thinks a PET/CT scan with PYLARIFY® is appropriate for you,
here are a few things to help you understand the procedure:

Upon arrival

Your weight and height will be measured and recorded
An intravenous (IV) catheter line will be placed in your arm or similar vein

You'll receive an injection of PYLARIFY® 1 hour prior to your PET/CT scan

It'll take approximately 1 hour for PYLARIFY® to circulate through your bloodstream and into any cancer cells that may be present
You may be asked to use the restroom after your injection of PYLARIFY® and prior to starting your scan

During the procedure

After you've received your injection of PYLARIFY®, you'll lie on your back on the scanner bed with your arms raised above your head; a trained PET/CT technologist or nurse will be there to help

The scanner bed will move slowly into the scanner and the scan will begin. The scan will be painless

The scan will typically start at your mid-thigh and go all the way up to your head
The scan could last up to 40 minutes and you may be asked to change body positions

After your scan

The results will be sent to your doctor

Be sure to continue to hydrate and go to the bathroom for the first few hours

Schedule a follow-up appointment with your doctor so together you can see and review the results and discuss a treatment plan

CT=computed tomography; PET=positron emission tomography.

WHAT COMES NEXT...

We've compiled resources to help you prepare for your visits, further explain prostate cancer, and provide information about PET/CT scans with PYLARIFY®.

VIEW RESOURCES

APPROVED USE

PYLARIFY® (piflufolastat F 18) Injection is a radioactive diagnostic agent. PYLARIFY is used along with positron emission tomography (PET) imaging for men with prostate cancer:

with suspected metastasis who are candidates for initial definitive therapy.

APPROVED USE

PYLARIFY® (piflufolastat F 18) Injection is a radioactive diagnostic agent. PYLARIFY is used along with positron emission tomography (PET) imaging for men with prostate cancer:

with suspected metastasis who are candidates for initial definitive therapy.
with suspected recurrence based on elevated serum levels of prostate-specific antigen (PSA) level.

PYLARIFY Injection is designed to detect prostate-specific membrane antigen (PSMA) positive lesions when used with PET imaging (scans).

IMPORTANT SAFETY INFORMATION

How well does PYLARIFY work?

As with all diagnostic imaging tests such as x-rays, bone scans, and computed tomography (CT) scans, it is possible that the physician (a radiologist or nuclear medicine physician) that reviews your PYLARIFY PET/CT scan could interpret your results incorrectly. This means that a negative PYLARIFY PET/CT scan does not rule out that you have prostate cancer, and a positive PYLARIFY PET/CT scan does not confirm that you have prostate cancer.
PYLARIFY seems to be affected by the amount (level) of PSA in your blood. As the levels of PSA in your blood go up, a PYLARIFY PET/CT scan is better able to identify prostate cancer.

Hypersensitivity reactions:

Patients should be monitored for hypersensitivity reactions, especially those with a history of allergy to other drugs and foods. Reactions may be delayed. Always have trained staff and resuscitation equipment available.

Radiation exposure:

PYLARIFY is a radioactive diagnostic agent and adds to your long-term overall amount of radiation exposure, which could lead to an increased risk of cancer. You should stay well hydrated before, during, and after you are given PYLARIFY and urinate frequently to reduce radiation exposure.

What are the possible side effects of PYLARIFY?

There were no serious reactions reported in patients who received scans in clinical trials with PYLARIFY, but some patients did report side effects associated with the use of PYLARIFY.
The most commonly reported adverse reactions are headache, fatigue and unusual taste in the mouth. An allergic reaction to PYLARIFY was reported in one patient with a significant history of allergic reactions.

Tell your doctor if you have any side effect that bothers you or does not go away.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-888-INFO-FDA (1-888-463-6332).

For more information, please see Full Prescribing information for PYLARIFY.

TALKING ABOUT PROSTATE CANCER AND PYLARIFY®. CLEARLY.

HOW TO PREP FOR A PET/CT SCAN WITH PYLARIFY®

After your scan

APPROVED USE

Leaving patient site

We are using cookies on this site

This link will take you to another website not owned by Lantheus

This link will take you to another
website not owned by Lantheus